A recent New York Post article discussed a potentially groundbreaking vaccine that stands to change the way we combat pancreatic cancer. The vaccine uses the same mRNA technology used by BioNTech and Pfizer for their COVID shot. A trial conducted at the Memorial SloanKettering Cancer Center in New York City showed that the vaccine could boost immune cells that target tumors to essentially train the immune system to kill pancreatic cancer cells.
